Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma

This study has suspended participant recruitment.
Sponsor:
Information provided by (Responsible Party):
Washington Hospital Center
ClinicalTrials.gov Identifier:
NCT01206296
First received: September 20, 2010
Last updated: March 11, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)